Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0565 USD | +4.63% |
|
-32.42% | +59.60% |
06-07 | CV Sciences, Inc. Elects Bill Mccorkle as Directors | CI |
06-03 | Transcript : CV Sciences, Inc. - Shareholder/Analyst Call |
Chart calendar CV Sciences, Inc.
Upcoming events on CV Sciences, Inc.
Past events on CV Sciences, Inc.
2024-06-03 13:00 | Annual General Meeting |
2024-05-14 10:00 | Q1 2024 Earnings Call |
2024-05-14 09:00 | Q1 2024 Earnings Release |
2024-03-28 10:00 | Q4 2023 Earnings Call |
2024-03-28 09:00 | Q4 2023 Earnings Release |
2023-11-14 10:00 | Q3 2023 Earnings Call |
2023-11-14 09:00 | Q3 2023 Earnings Release |
2023-10-04 18:00 | LD Micro Main Conference |
2023-08-14 10:00 | Q2 2023 Earnings Call |
2023-08-14 09:00 | Q2 2023 Earnings Release |
2023-06-07 00:00 | LD Micro Invitational Conference |
2023-06-01 13:00 | Annual General Meeting |
2023-05-15 10:00 | Q1 2023 Earnings Call |
2023-05-15 09:00 | Q1 2023 Earnings Release |
2023-03-29 10:00 | Q4 2022 Earnings Call |
2023-03-29 09:00 | Q4 2022 Earnings Release |
2022-11-14 10:00 | Q3 2022 Earnings Call |
2022-11-14 09:00 | Q3 2022 Earnings Release |
2022-08-15 10:00 | Interim 2022 Earnings Call |
2022-08-15 09:00 | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 53,7 56,0 -4.03% | 24,4 25,8 -5.26% | 20,0 20,3 -1.04% |
EBITDA Million USD | Released Forecast Spread | 0,18 2,68 -93.25% | -11,6 -11,3 -2.48% | -9,96 -9,20 -8.19% |
EBIT Million USD | Released Forecast Spread | -17,2 -12,3 -40.26% | -22,6 -15,4 -46.88% | -18,4 -12,4 -48.51% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,2 -10,9 -58.63% | -22,6 -15,4 -47.21% | -15,6 -9,54 -63.91% |
Net income Million USD | Released Forecast Spread | -16,6 -10,4 -59.2% | -22,3 -14,9 -49.99% | -15,6 -9,55 -62.81% |
EPS USD | Released Forecast Spread | -0,17 -0,10 -70% | -0,22 -0,14 -57.14% | -0,14 -0,09 -55.56% |
Announcement Date | 16/03/20 | 18/03/21 | 31/03/22 |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,45 4,84 -8.07% | 4,14 4,88 -15.27% | |
EBITDA Million USD | Released Forecast Spread | -2,48 -1,95 -27.08% | -1,83 -2,06 11.16% | |
EBIT Million USD | Released Forecast Spread | -1,52 -3,20 52.62% | -2,32 -3,06 24.23% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,22 -3,31 33.08% | -2,65 -3,18 16.64% | |
Net income Million USD | Released Forecast Spread | -2,22 -3,31 33.07% | -3,57 -3,18 -12.34% | -1,03 |
EPS USD | Released Forecast Spread | -0,02 -0,03 33.33% | -0,03 -0,03 0% | -0,01 |
Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 |
Past sector events for CV Sciences, Inc.
2024-06-21 11:28 | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 17:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVSI Stock
- Calendar CV Sciences, Inc.